TIAA CREF INVESTMENT MANAGEMENT LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$1,467,000
+2.3%
71,797
-0.3%
0.00%0.0%
Q4 2018$1,434,000
-49.5%
72,043
-51.2%
0.00%0.0%
Q3 2018$2,840,000
+135.7%
147,638
+86.9%
0.00%0.0%
Q2 2018$1,205,000
-51.3%
78,987
-40.1%
0.00%
-50.0%
Q1 2018$2,474,000
+42.8%
131,942
+46.4%
0.00%
+100.0%
Q4 2017$1,733,000
+1.0%
90,094
-6.1%
0.00%0.0%
Q3 2017$1,715,000
-2.2%
95,954
-2.2%
0.00%0.0%
Q2 2017$1,753,000
+5.4%
98,150
-14.4%
0.00%0.0%
Q1 2017$1,663,000
-30.7%
114,668
-12.0%
0.00%
-50.0%
Q4 2016$2,400,000
-8.2%
130,294
-5.4%
0.00%0.0%
Q3 2016$2,614,000
+23.4%
137,797
+4.8%
0.00%0.0%
Q2 2016$2,119,000
+70.2%
131,425
+26.7%
0.00%
+100.0%
Q1 2016$1,245,000
-36.4%
103,741
-24.6%
0.00%0.0%
Q4 2015$1,959,000
+59.3%
137,641
+30.8%
0.00%0.0%
Q3 2015$1,230,000
-6.2%
105,219
+40.9%
0.00%0.0%
Q2 2015$1,312,000
+306.2%
74,656
+246.2%
0.00%
Q1 2015$323,000
+29.2%
21,5620.0%0.00%
Q4 2014$250,000
+12.6%
21,562
+12.9%
0.00%
Q3 2014$222,00019,0950.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders